These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23651541)

  • 1. Patients' worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009.
    Mayanja BN; Ekoru K; Namugenyi H; Lubega R; Mugisha JO
    BMC Res Notes; 2013 May; 6():187. PubMed ID: 23651541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult patients' adherence to anti-retroviral treatment: a survey correlating pharmacy refill records and pill counts with immunological and virological indices.
    Ndubuka NO; Ehlers VJ
    Int J Nurs Stud; 2011 Nov; 48(11):1323-9. PubMed ID: 21570684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort.
    Mayanja BN; Kabunga E; Masiira B; Lubega R; Kaleebu P; Seeley J
    Afr Health Sci; 2013 Jun; 13(2):311-9. PubMed ID: 24235929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort.
    Kipp W; Konde-Lule J; Saunders LD; Alibhai A; Houston S; Rubaale T; Senthilselvan A; Okech-Ojony J
    PLoS One; 2012; 7(7):e40902. PubMed ID: 22815862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
    Izudi J; Alioni S; Kerukadho E; Ndungutse D
    BMC Infect Dis; 2016 Oct; 16(1):614. PubMed ID: 27793124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004-2009.
    Mayanja BN; Shafer LA; Van der Paal L; Kyakuwa N; Ndembi N; Hughes P; Maher D; Grosskurth H
    Trop Med Int Health; 2012 Mar; 17(3):343-52. PubMed ID: 22212561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
    Muyingo SK; Walker AS; Reid A; Munderi P; Gibb DM; Ssali F; Levin J; Katabira E; Gilks C; Todd J;
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):468-75. PubMed ID: 18614918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems.
    Erb S; Letang E; Glass TR; Natamatungiro A; Mnzava D; Mapesi H; Haschke M; Duthaler U; Berger B; Muri L; Bader J; Marzolini C; Elzi L; Klimkait T; Langewitz W; Battegay M;
    HIV Med; 2017 Oct; 18(9):623-634. PubMed ID: 28296019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a community-based antiretroviral treatment program for HIV-1 infection in Western Uganda.
    Kipp W; Konde-Lule J; Saunders LD; Alibhai A; Houston S; Rubaale T; Senthilselvan A; Okech-Ojony J; Kiweewa F
    Curr HIV Res; 2010 Mar; 8(2):179-85. PubMed ID: 20163349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa.
    Haberer JE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Siedner MJ; Matthews LT; Tsai AC; Katz IT; Bell K; Kembabazi A; Mugisha S; Kibirige V; Cross A; Kelly N; Hedt-Gauthier B; Bangsberg DR
    J Int AIDS Soc; 2019 Feb; 22(2):e25232. PubMed ID: 30746898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.
    Kiwuwa-Muyingo S; Oja H; Walker A; Ilmonen P; Levin J; Mambule ; Reid A; Mugyenyi P; Todd J;
    BMC Infect Dis; 2013 Aug; 13():395. PubMed ID: 24060199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.